AlloCare – Page 70

January 26, 2023January 26, 2023

JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice

JANUARY, 26, 2023

Guide Helps Transplant Centers Continue the Evolution from Endomyocardial Biopsies to Noninvasive Surveillance Using AlloMap GEP and AlloSure dd-cfDNA

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Journal of the American College of Cardiology (JACC): Heart Failure has published a detailed guide¹ to help clinicians transition from routine invasive endomyocardial biopsy (EMB) to a less invasive acute rejection monitoring protocol in clinical practice.

January 25, 2023January 25, 2023

Depression, anxiety tied to less ideal CV health in young adults

Depression and anxiety in young adults are associated with less ideal CV health, which may be improved with a better diet, physical activity and improved sleep, researchers reported.

“Mechanisms linking mental health and cardiovascular health are likely multifactorial. Read more in Healio.

January 25, 2023January 25, 2023

Kidney Transplant Recipients Do Not Benefit From Infliximab Induction

Infliximab induction therapy fails to protect kidney transplants and appears to increase the risk of BK virus infection in recipients, investigators report.

Peter Heeger, MD, of the Comprehensive Transplant Center at Cedars Sinai Medical Center in West Hollywood, California, and colleagues randomly assigned 225 unsensitized recipients of deceased-donor kidneys to receive intravenous infliximab (3 mg/kg) or saline placebo prior to kidney reperfusion. Read the full story in Renal & Urology News.

January 24, 2023January 24, 2023

Researchers confirm successful rehabilitation and recovery of human donor lungs previously deemed unfit for transplant

Study demonstrates that a novel technique for regenerating donor lungs can increase the number of organs available for life-saving transplantation

NEW YORK, Jan. 23, 2023 /PRNewswire/ — A novel method for supporting and recovering donor lungs outside the body shows potential to increase the number of organs available for transplant, according to a recent study published in The Journal of Heart and Lung Transplantation. Read the complete press release on Yahoo.com.

January 24, 2023January 24, 2023

Widely used test kept Black people from getting kidney transplants sooner. Now that’s changing.

Kristal Higgins just wants to be healthy, become a nurse and travel to Greece. But she has kidney failure and has been on a transplant waiting list for six years.

The disease and its comorbidities have touched many of her loved ones. Her mother has stage 2 kidney disease. Her father is diabetic, a risk factor for kidney failure, as was her late grandmother. Several of her relatives have kidney failure. Read more in USA Today.

January 23, 2023January 23, 2023

With demand soaring for heart transplants, Florida hospitals ramp up

In Florida, demand has never been higher.

Ten hospitals in the state perform heart transplants, each with their own criteria. As the year kicks off, more than 200 people are on the wait list, according to the Organ Procurement Transplantation Network. Read more in Medical Xpress.

January 23, 2023January 23, 2023

Kidney Transplant Outcomes in Recipients Over the Age of 70

Published: January 20, 2023 (see history)

Cite this article as: Mehta J, Ndubueze O, Tatum D, et al. (January 20, 2023) Kidney Transplant Outcomes in Recipients Over the Age of 70. Cureus 15(1): e34021. doi:10.7759/cureus.34021

Abstract

Background: Patients older than 70 years are the fastest-growing age group of patients requiring renal replacement therapy. This has resulted in a corresponding increase in the number of elderly transplant recipients. We hypothesized that graft survival in this population would be comparable to that seen in the literature on kidney transplant recipients under 70 years of age. Read the complete abstract in Cureus.

January 22, 2023January 19, 2023

Migraine, severe headache history associated with hypertension risk

U.S. adults who reported a history of migraine or severe headache were 25% more likely to develop hypertension compared with those with no migraine history, with a higher risk for women vs. men, researchers reported. Read more in Healio.

January 22, 2023January 19, 2023

Neurological effects of long COVID: It is ‘not only a respiratory disease’

As the world continues to grapple with effects of the COVID-19 pandemic, individuals around the globe are still dealing with symptoms of SARS-CoV-2 infection for months, even years, after their initial infection.

Post-acute sequelae of COVID-19, more commonly referred to as long COVID, are defined by the CDC as a wide range of new, returning or ongoing health issues that people experience after being infected with SARS-CoV-2, the virus that causes COVID-19.
Read more from Healio.

January 21, 2023January 19, 2023

Kidney Transplant Rejection: What You Need to Know

Since the first kidney transplant more than 60 years ago,¹ doctors have developed a deeper understanding of how to protect donated organs. With newer medications and improved management, it’s less likely transplanted kidneys will undergo rejection by the immune system. Read the full story on CareDx.com.